{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:35:16Z","timestamp":1776954916546,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/PR5693\/MED\/29\/585\/2012"],"award-info":[{"award-number":["BT\/PR5693\/MED\/29\/585\/2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jdiacomp.2022.108133","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T02:11:24Z","timestamp":1642817484000},"page":"108133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Serum levels of novel anti-inflammatory cytokine Interleukin-38 in diabetes patients infected with latent tuberculosis (DM-LTB-3)"],"prefix":"10.1016","volume":"36","author":[{"given":"Vivekanandhan","family":"Aravindhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anup","family":"Bobhate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuppan","family":"Sathishkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2022.108133_bb0005","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0010","first-page":"399","article-title":"Tuberculosis and diabetes mellitus: merging epidemics","volume":"57","author":"Sen","year":"2009","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0015","doi-asserted-by":"crossref","first-page":"6264149","DOI":"10.1155\/2016\/6264149","article-title":"Metainflammation in diabetic coronary artery disease: emerging role of innate and adaptive immune responses","volume":"2016","author":"Aravindhan","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/eem.09.44","article-title":"Diabetes is a proinflammatory state: a translational perspective","volume":"5","author":"Devaraj","year":"2010","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc09-1799","article-title":"Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects","volume":"33","author":"Dasu","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155333","article-title":"Anti-inflammatory cytokines IL-27, IL-10, IL-1Ra and TGF-beta in subjects with increasing grades of glucose intolerence (DM-LTB-2)","volume":"137","author":"Bobhate","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107528","article-title":"Biology of interleukin-38 and its role in chronic inflammatory diseases","volume":"95","author":"Xia","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/imr.12612","article-title":"Biology of IL-38 and its role in disease","volume":"281","author":"van de Veerdonk","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108585","article-title":"Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes","volume":"171","author":"Gurau","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106264","article-title":"Interleukin-38 increases the insulin sensitivity in children with the type 2 diabetes","volume":"82","author":"Liu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jri.2017.09.011","article-title":"IL-37 and 38 signalling in gestational diabetes","volume":"124","author":"Yu","year":"2017","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbrc.2018.11.114","article-title":"Hydrodynamic delivery of IL-38 gene alleviates obesity-induced inflammation and insulin resistance","volume":"508","author":"Xu","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0065","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/db08-0564","article-title":"High glucose induces toll-like receptor expression in human monocytes: mechanism of activation","volume":"57","author":"Dasu","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0070","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/eji.201948390","article-title":"Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects","volume":"51","author":"de Graaf","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0075","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.metabol.2010.06.003","article-title":"Decreased serum interleukin-17 and increased transforming growth factor-beta levels in subjects with metabolic syndrome (Chennai urban rural epidemiology Study-95)","volume":"60","author":"Surendar","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0080","first-page":"1311","article-title":"Inverse relationship of serum IL-17 with type-II diabetes retinopathy","volume":"59","author":"Nadeem","year":"2013","journal-title":"Clin Lab"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0085","article-title":"Serum IL-36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammation","volume":"35","author":"Li","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.resinv.2017.06.001","article-title":"Overexpression of IL-38 protein in anticancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis","volume":"55","author":"Tominaga","year":"2017","journal-title":"Respir Investig"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181598","article-title":"Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: possible association with PD-L1 expression","volume":"12","author":"Takada","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2022.108133_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21070933","article-title":"Aberrant expression of novel cytokine IL-38 and regulatory T lymphocytes in childhood asthma","volume":"21","author":"Chu","year":"2016","journal-title":"Molecules"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:14:25Z","timestamp":1761005665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872722000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1056872722000095"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108133","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum levels of novel anti-inflammatory cytokine Interleukin-38 in diabetes patients infected with latent tuberculosis (DM-LTB-3)","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108133"}}